A recent ECDC study shows that communication around the benefit and risk balance of vaccination is a complex undertaking and therefore requires a mix of different communication approaches to ensure impact across multiple audiences.
This report presents the results of a study that dealt specifically with effective communication around the benefit and risk balance of vaccination people’s risk perceptions around vaccines and diseases, and approaches to enhancing communication about the safety and effectiveness of vaccines.
In 2022, 27 European Union/European Economic Area (EU/EEA) countries reported 731 echinococcosis cases. Of these, 299 (41%) cases were reported as Echinococcus granulosus sensu lato, 185 (25%) as E. multilocularis and 247 (34%) as an unknown species.
In 2022, 28 European Union/European Economic Area (EU/EEA) countries reported 39 cases of trichinellosis, which represented a 49% decrease compared with 2021.
ECDC, DG SANTE and EFSA, supported by a consortium composed of Epiconcept and Integrated Quality Laboratory Services (IQLS), jointly carried out a country visit to Kosovo* from 9 to 13 October 2023, which is part of ECDC’s accession support activities to contribute to the advancement of a One Health approach against antimicrobial resistance (AMR) in the Western Balkans.
Video on the new framework for prevention of infectious diseases, which is based on social and behavioural sciences, health promotion, health literacy and health education.